Reviva Pharmaceuticals Holdings, Inc. (RVPH) Operating cash flow 2019–2025
Reviva Pharmaceuticals Holdings, Inc. (RVPH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$24.6MFY2025 · since FY2019: -$218,444 → -$24.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.6M | +26.7% |
| FY2024 | -$33.5M | -18.4% |
| FY2023 | -$28.3M | -49.4% |
| FY2022 | -$19.0M | -77.7% |
| FY2021 | -$10.7M | -162.3% |
| FY2020 | -$4.1M | -1761.6% |
| FY2019 | -$218,444 | — |
Source: SEC XBRL filings · For reference only · Not investment advice